ENDURANT CAPITAL MANAGEMENT LP Mirati Therapeutics, Inc. Transaction History

ENDURANT CAPITAL MANAGEMENT LP portfolio value:

$553,000
portfolio value

Mirati Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 7.91K shares 553K $69.84 7.91K